摘要
用胎脾LAK细胞加rIL-2治疗中晚期恶性肿瘤51例,其中CR3例,PR7例,有效率CR+PR为19.6%,CR+PR+MR为31.4%。大多数患者临床症状改善,生活质量提高,生存期延长,治疗中未见严重副反应。
With LAK cells from fetal splenocytes plus rIL-2,51 cases of malignant patients at the coddle and advanced stages were treated. Of them,3 cases were complete response (CR),7 cases partial response (PR),and curative effects were 19. 6%(CR+PR) or 31.4% (CR+PR+MR).In most of the patients,the clinical symptoms and living quality were improved,and the periods of survival extended. No severe toxic side effects werefound.